Literature DB >> 26507679

Defective mutations within the translocation domain of Clostridium difficile toxin B impair disease pathogenesis.

Therwa Hamza1, Zhifen Zhang2, Roman A Melnyk3, Hanping Feng4.   

Abstract

The Clostridium difficile toxin B is one of the main virulence factors and plays an important role in the pathogenesis of C. difficile infection (CDI). We recently revealed crucial residues in the translocation domain of TcdB for the pore formation and toxin translocation. In this study, we investigated the effects of mutating a critical site involved in pore formation, Leu-1106, to residues that differ in size and polarity (Phe, Ala, Cys, Asp). We observed a broad range of effects on TcdB function in vitro consistent with the role of this site in pore formation and translocation. We show that mice challenged systemically with a lethal dose (LD100) of the most defective mutant (L1106K) showed no symptoms of disease highlighting the importance of this residue and the translocation domain in disease pathogenesis. These findings offer insights into the structure function of the toxin translocation pore, and inform novel therapeutic strategies against CDI. © FEMS 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Clostridium difficile; TcdB; toxin; translocation domain

Mesh:

Substances:

Year:  2015        PMID: 26507679      PMCID: PMC4882082          DOI: 10.1093/femspd/ftv098

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  23 in total

1.  Autocatalytic cleavage of Clostridium difficile toxin B.

Authors:  Jessica Reineke; Stefan Tenzer; Maja Rupnik; Andreas Koschinski; Oliver Hasselmayer; André Schrattenholz; Hansjörg Schild; Christoph von Eichel-Streiber
Journal:  Nature       Date:  2007-03-04       Impact factor: 49.962

2.  Membrane insertion by anthrax protective antigen in cultured cells.

Authors:  Maen Qa'dan; Kenneth A Christensen; Lei Zhang; Thomas M Roberts; R John Collier
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

Review 3.  Clostridium difficile--more difficult than ever.

Authors:  Ciarán P Kelly; J Thomas LaMont
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

4.  Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin B.

Authors:  Selda Genisyuerek; Panagiotis Papatheodorou; Gregor Guttenberg; Rolf Schubert; Roland Benz; Klaus Aktories
Journal:  Mol Microbiol       Date:  2011-01-28       Impact factor: 3.501

5.  Fatal pseudomembranous colitis associated with a variant clostridium difficile strain not detected by toxin A immunoassay.

Authors:  S Johnson; S A Kent; K J O'Leary; M M Merrigan; S P Sambol; L R Peterson; D N Gerding
Journal:  Ann Intern Med       Date:  2001-09-18       Impact factor: 25.391

6.  Glucosyltransferase activity of Clostridium difficile Toxin B is essential for disease pathogenesis.

Authors:  Zhiyong Yang; Yongrong Zhang; Tuxiong Huang; Hanping Feng
Journal:  Gut Microbes       Date:  2015-06-19

7.  Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity.

Authors:  Martina Egerer; Torsten Giesemann; Thomas Jank; Karla J Fullner Satchell; Klaus Aktories
Journal:  J Biol Chem       Date:  2007-06-25       Impact factor: 5.157

8.  Effects of Clostridium difficile toxins given intragastrically to animals.

Authors:  D M Lyerly; K E Saum; D K MacDonald; T D Wilkins
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

9.  Identification of toxemia in patients with Clostridium difficile infection.

Authors:  Hua Yu; Kevin Chen; Jianguo Wu; Zhiyong Yang; Lianfa Shi; Lydia L Barlow; David M Aronoff; Kevin W Garey; Tor C Savidge; Erik C von Rosenvinge; Ciaran P Kelly; Hanping Feng
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

10.  A segment of 97 amino acids within the translocation domain of Clostridium difficile toxin B is essential for toxicity.

Authors:  Yongrong Zhang; Lianfa Shi; Shan Li; Zhiyong Yang; Clive Standley; Zhong Yang; Ronghua ZhuGe; Tor Savidge; Xiaoning Wang; Hanping Feng
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

View more
  3 in total

1.  Murine Intrarectal Instillation of Purified Recombinant Clostridioides difficile Toxins Enables Mechanistic Studies of Pathogenesis.

Authors:  Nicholas O Markham; Sarah C Bloch; John A Shupe; Erin N Laubacher; Audrey K Thomas; Heather K Kroh; Kevin O Childress; F Christopher Peritore-Galve; M Kay Washington; Robert J Coffey; D Borden Lacy
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

Review 2.  Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects.

Authors:  Stefano Di Bella; Paolo Ascenzi; Steven Siarakas; Nicola Petrosillo; Alessandra di Masi
Journal:  Toxins (Basel)       Date:  2016-05-03       Impact factor: 4.546

3.  Clostridioides difficile Toxin A Remodels Membranes and Mediates DNA Entry Into Cells to Activate Toll-Like Receptor 9 Signaling.

Authors:  Xinhua Chen; Xiaotong Yang; Jaime de Anda; Jun Huang; Dan Li; Hua Xu; Kelsey S Shields; Mária Džunková; Joshua Hansen; Ishan J Patel; Eric U Yee; Douglas T Golenbock; Marianne A Grant; Gerard C L Wong; Ciarán P Kelly
Journal:  Gastroenterology       Date:  2020-08-22       Impact factor: 22.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.